In June 2010 The Board Of Directors Of Rvc Has Approved The Conceptual Framework Of Rvc Biofundin Early 2011The Fund Started Its Operations The Biofund Was Necessitated By A Low Share Of Russian Innovative Drugsamounting Today To Less Than 1 With Virtually Zero Infrastructure To Develop Biopharma And Medical Start Upsforeign Services Devour 50To 80Of Russian Investment Resourcesto Remedy Thisrvc Biofund Will Be Investing Capital Into Service Companies Of This Cluster And Biotech Start Upsadditionallyit Will Be Launching An Ecosystem To Generate And Incubate As Many Biotech Projects As Possible The Fund Focus Covers Innovative Biopharma Companies And Service Companies Providing Contractlaboratoryanalytical And Consulting Services To Biotechnologicalpharmaceutical And Medical Companies
